RPG Life Sciences
Rpg Life Sciences Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in RPG Life Sciences
Start SIPRpg Life Sciences Investment Rating
-
Master Rating:
-
R P G Life Sciences has an operating revenue of Rs. 512.81 Cr. on a trailing 12-month basis. An annual revenue growth of 17% is outstanding, Pre-tax margin of 18% is great, ROE of 21% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 97 which is a GREAT score indicating consistency in earnings, a RS Rating of 56 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 112 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 118 | 131 | 135 | 129 | 104 |
| Operating Expenses Qtr Cr | 103 | 101 | 105 | 101 | 90 |
| Operating Profit Qtr Cr | 16 | 29 | 30 | 28 | 14 |
| Depreciation Qtr Cr | 4 | 4 | 4 | 4 | 4 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 3 | 7 | 7 | 7 | 3 |
| Net Profit Qtr Cr | 10 | 19 | 20 | 18 | 8 |
Rpg Life Sciences Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 13
- Bearish Moving Average
- ___
- 3
- 20 Day
- ₹774.16
- 50 Day
- ₹777.74
- 100 Day
- ₹785.6
- 200 Day
- ₹767.38
- 20 Day
- ₹774.4
- 50 Day
- ₹764.75
- 100 Day
- ₹794.67
- 200 Day
- ₹806.95
Rpg Life Sciences Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹788.84 |
| Second Resistance | ₹797.87 |
| Third Resistance | ₹806.74 |
| RSI | 57.17 |
| MFI | 50.34 |
| MACD Single Line | -1.89 |
| MACD | -0.91 |
| Support | |
|---|---|
| First Resistance | ₹770.94 |
| Second Resistance | ₹762.07 |
| Third Resistance | ₹753.04 |
Rpg Life Sciences Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 20,983 | 849,182 | 40.47 |
| Week | 16,722 | 975,394 | 58.33 |
| 1 Month | 19,291 | 1,188,351 | 61.6 |
| 6 Month | 30,649 | 1,261,799 | 41.17 |
Rpg Life Sciences Result Highlights
RPG Life Sciences Synopsis
NSE-Medical-Diversified
Rpg Life Sciences is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 512.81 Cr. and Equity Capital is Rs. 13.23 Cr. for the Year ended 31/03/2023. RPG Life Sciences Ltd. is a Public Limited Listed company incorporated on 29/03/2007 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24232MH2007PLC169354 and registration number is 169354.| Market Cap | 1,309 |
| Sales | 513 |
| Shares in Float | 0.45 |
| No of funds | 21 |
| Yield | 1.52 |
| Book Value | 4.26 |
| U/D Vol ratio | 0.9 |
| LTDebt / Equity | |
| Alpha | 0.2 |
| Beta | 0.71 |
RPG Life Sciences
| Owner Name | Mar-23 | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|---|
| Promoters | 72.81% | 72.61% | 72.61% | 72.41% |
| Mutual Funds | ||||
| Foreign Portfolio Investors | 0.38% | 0.25% | 0.08% | 0.15% |
| Financial Institutions/ Banks | 0.01% | 0.01% | 0.01% | |
| Individual Investors | 19.91% | 20.26% | 19.91% | 20.37% |
| Others | 6.9% | 6.87% | 7.39% | 7.06% |
RPG Life Sciences Management
| Name | Designation |
|---|---|
| Mr. Harsh V Goenka | Chairman |
| Mr. Yugal Sikri | Managing Director |
| Mr. Rajat Bhargava | Non Executive Director |
| Mr. Sachin Nandgaonkar | Non Executive Director |
| Mr. Manoj K Maheshwari | Independent Director |
| Mr. Narendra Ambwani | Independent Director |
| Ms. Zahabiya Khorakiwala | Independent Director |
| Mr. Bhaskar Iyer | Independent Director |
| Dr. Lalit S Kanodia | Independent Director |
| Mr. Mahesh S Gupta | Independent Director |
Rpg Life Sciences Forecast
Price Estimates
Rpg Life Sciences Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-04-28 | Audited Results & Final Dividend | |
| 2023-02-01 | Quarterly Results | |
| 2022-10-17 | Quarterly Results | |
| 2022-08-02 | Quarterly Results | |
| 2022-04-29 | Audited Results |
| Date | Purpose | Remarks |
|---|---|---|
| 2022-07-15 | FINAL | Rs.9.60 per share(120%)Final Dividend |
| 2021-08-17 | FINAL | Rs.7.20 per share(90%)Dividend |
RPG Life Sciences FAQs
What is Share Price of RPG Life Sciences ?
RPG Life Sciences share price is ₹791 As on 04 June, 2023 | 19:59
What is the Market Cap of RPG Life Sciences ?
The Market Cap of RPG Life Sciences is ₹1309.1 Cr As on 04 June, 2023 | 19:59
What is the P/E ratio of RPG Life Sciences ?
The P/E ratio of RPG Life Sciences is 19.4 As on 04 June, 2023 | 19:59
What is the PB ratio of RPG Life Sciences ?
The PB ratio of RPG Life Sciences is 4.3 As on 04 June, 2023 | 19:59